Exploring metacognitive function in patients with opioid use disorder: A pilot study
Abstract Objectives Despite recognised cognitive deficits related to substance use, as well as high mortality and treatment attrition rates, metacognition has never been studied in patients with opioid use disorder (OUD) undergoing opioid maintenance treatment (OMT).
John Hanson Högberg +3 more
wiley +1 more source
Efficacy of naltrexone and bupropion combination in patients with binge eating disorder: a systematic review and meta-analysis. [PDF]
Roudbaraki SN +3 more
europepmc +1 more source
Abstract Introduction Self‐harm is common in people who experience disordered eating. It is unclear whether those who self‐harm with disordered eating have distinct characteristics and needs compared to those who self‐harm without co‐occurring disordered eating. Methods Data were obtained from the Manchester Self‐Harm Project. Information was extracted
Elana Moore +5 more
wiley +1 more source
Visible yet Invisible: embodied meanings of weight stigma among women with binge eating disorder and higher weight. [PDF]
Berg KH, Natvik E, Jahren L, Eik-Nes TT.
europepmc +1 more source
Periodontitis and metabolic dysfunction‐associated steatotic liver disease
Abstract Objective Periodontitis is a chronic inflammatory disease with systemic effects that extend beyond the oral cavity and contribute to systemic immune and metabolic dysregulation. Chronic liver diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive phenotypes, have emerged as major global ...
Rafael Scaf de Molon +6 more
wiley +1 more source
Exploring lifestyle management in polycystic ovary syndrome through implementation frameworks
Abstract Polyendocrine metabolic ovarian syndrome [PMOS; previously known as polycystic ovary syndrome (PCOS)] is an endocrine condition affecting 10%–13% of women of reproductive age, with cardiometabolic, reproductive and psychological features. The PMOS guidelines have established recommendations for its management, which can include pharmacological,
Margaret McGowan +4 more
wiley +1 more source
Smartphone-Supported Cognitive-Behavioral Therapy in Binge-Eating Disorder: An Exploratory Randomized Trial. [PDF]
Hilbert A +4 more
europepmc +1 more source
ABSTRACT Objective Comorbidity between Eating Disorders (ED) and Emotionally Unstable Personality Disorder (EUPD) is high. This comorbidity is also linked with worse outcomes for traditional evidence‐based treatments. We aimed to improve mental health service experience for adults with comorbid EUPD and ED by: (1) understanding the service‐user ...
Amy Lunn +6 more
wiley +1 more source
Farnesoid X Receptor Agonist INT‐787 Protects Human Liver Organoids From Alcohol‐Induced Injury
ABSTRACT Background Alcohol‐associated liver disease (ALD) represents a spectrum of liver injury ranging from steatosis to alcohol‐associated hepatitis, cirrhosis, and hepatocellular carcinoma. Activation of the farnesoid X receptor (FXR) decreases liver steatosis, inflammation, and fibrosis in animal models of liver‐related diseases, including ...
Francesca De Franco +8 more
wiley +1 more source
Self-harm in individuals who experience binge eating disorder: A systematic review and meta-analysis. [PDF]
Moore E +4 more
europepmc +1 more source

